From the Guidelines
The maximum recommended dose of metformin is 2,000 to 2,550 mg per day, as indicated in the most recent guidelines 1.
Key Considerations for Metformin Dosage
- The dosage should be individualized based on effectiveness and tolerance, with lower doses recommended for elderly patients and those with reduced kidney function.
- For immediate-release metformin, patients usually start with 500 mg twice daily with meals, gradually increasing to the maximum dose as needed and tolerated.
- For extended-release formulations, the maximum is typically 2,000 mg once daily with the evening meal.
- Metformin works by decreasing glucose production in the liver, reducing intestinal absorption of glucose, and improving insulin sensitivity.
Important Side Effects and Monitoring
- Side effects like gastrointestinal disturbances (nausea, diarrhea) are common, especially when starting treatment, which is why gradual dose increases are recommended.
- Regular kidney function monitoring is essential as metformin is contraindicated in patients with significantly impaired kidney function (eGFR below 30 mL/min) due to increased risk of lactic acidosis, a rare but serious side effect, as noted in 1.
Clinical Guidance
- The American Diabetes Association and the European Association for the Study of Diabetes have provided consensus algorithms for the initiation and adjustment of therapy, including metformin, in the management of type 2 diabetes 1.
- However, the most recent and highest quality evidence from 1 should guide clinical decision-making regarding metformin dosage.
Dosage Titration
- Begin with low-dose metformin (500 mg) taken once or twice per day with meals, and advance the dose based on tolerance and effectiveness, as suggested in earlier guidelines 1.
- The maximum effective dose can be up to 1,000 mg twice per day but is often 850 mg twice per day, with modestly greater effectiveness observed with doses up to about 2,500 mg/day, as indicated in 1.
From the FDA Drug Label
The recommended starting dose of metformin hydrochloride tablets are 500 mg orally twice a day or 850 mg once a day, given with meals. Increase the dose in increments of 500 mg weekly or 850 mg every 2 weeks on the basis of glycemic control and tolerability, up to a maximum dose of 2550 mg per day, given in divided doses. Doses above 2000 mg may be better tolerated given 3 times a day with meals. The recommended starting dose of metformin hydrochloride tablets for pediatric patients 10 years of age and older is 500 mg orally twice a day, given with meals. Increase dosage in increments of 500 mg weekly on the basis of glycemic control and tolerability, up to a maximum of 2000 mg per day, given in divided doses twice daily.
The maximum dose of metformin is 2550 mg per day for adults and 2000 mg per day for pediatric patients 10 years of age and older 2.
From the Research
Metformin Dosage and Lactic Acidosis
- The provided studies do not specify a maximum dosage of metformin that can be taken, but rather discuss the risks of lactic acidosis associated with its use 3, 4, 5, 6, 7.
- Lactic acidosis is a rare but serious complication of metformin use, with a mortality rate of approximately 50% 5, 6.
- The risk of lactic acidosis is increased in patients with reduced kidney function, congestive heart failure, and chronic liver disease 3, 4, 6.
- The studies suggest that the risk of lactic acidosis is not necessarily determined by the administration of metformin, but rather by underlying health conditions 3, 4, 7.
- Diabetes itself is a major risk factor for the development of lactic acidosis, rather than metformin therapy 7.
Factors Contributing to Lactic Acidosis
- Acute cardiorespiratory illness, acute renal impairment, and sepsis are common precipitating factors for lactic acidosis 7.
- Age, acute renal failure, and sepsis are associated with increased mortality from lactic acidosis 7.
- Metformin plasma concentration is not easily measurable in all laboratories, but can be used to diagnose metformin-associated lactic acidosis (MALA) 6.
- Renal replacement therapies have been successfully used to treat MALA, but the optimal treatment modality is still controversial 6.